Independent OSSTMM penetration testing by a Swiss security firm confirms Best-in-Class RAV score for Neev’s next gen ...
Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.
Planning your week in or around Albany? From Meek Mill at MVP Arena to "The Sound of Music" at Proctors, discover the best ...
Platform combines proprietary AI sequence optimization, novel genetic parts, and lab validation in application-relevant cell models to improve expression and half-life, delivering top candidates in ...
Quarterly Adjusted EBITDA -- $4.9 million, a $6.3 million improvement from negative $1.4 million in the prior year, with a ...
Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...
Viral vector gene therapy represents a rapidly advancing field at the intersection of molecular medicine, biotechnology, and clinical translation. Viral ...
Q4 2025 Earnings Call March 19, 2026 5:00 PM EDTCompany ParticipantsYojin Yoon - Vice President of OperationsJoshua ...
Applied Biopharm Consulting Ltd has been awarded an Intellectual Property (IP) Start Grant from the Local Enterprise Office under Enterprise Ireland’s IP Strategy initiative. The grant will support ...
Viral Vector Manufacturing Facility Pty Ltd (VVMF), Australia’s first commercial viral vector Contract Development and Manufacturing Organisation (CDMO), today announces that it has entered into a ...
Qdrant's $50M Series B and version 1.17 release make the case that agentic AI didn't simplify vector search — it scaled the ...
The research introduces a novel memory architecture called MSA (Memory Sparse Attention). Through a combination of the Memory Sparse Attention mechanism, Document-wise RoPE for extreme context ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results